GENE ONLINE|News &
Opinion
Blog

2018-04-26|

April 26, 1932: British-Canadian Biochemist Michael Smith Was Born

by GeneOnline
Share To

Michael Smith (April 26, 1932 – October 4, 2000) was a British-born Canadian biochemist. Smith collaborated with Clyde A. Hutchison to develop a new technique called “site-specific mutagenesis”, and was able to determine the effect of a single mutant gene. In 1978, Michael Smith used polymerase chain reaction (PCR) to successfully induce mutations at specific locations on DNA with certain primers. Therefore, in 1993, Simth and Kary Mullis, who invented the PCR technology, were awarded the 1993 Nobel Prize in Chemistry.

Reference
https://en.wikipedia.org/wiki/Michael_Smith_(chemist)

Image Source
http://www.msfhr.org/about/dr-michael-smith

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
R&D
Bacteriophage Characteristics Could Provide the Key to Tackling Viruses
2022-11-02
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top